alpha-aminopyridine has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhangal, G; Cook, HT; Jackson, WD; Masuda, ES; McAdoo, SP; McDaid, JP; Pusey, CD; Reynolds, J; Smith, J; Tam, FW; Tanna, A | 1 |
1 other study(ies) available for alpha-aminopyridine and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.
Topics: Aminopyridines; Animals; Anti-Glomerular Basement Membrane Disease; Antibody Formation; Autoantibodies; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats, Inbred WKY; Spleen; Syk Kinase | 2014 |